Analysts Weigh In On Amended Bluebird Bio/Celgene Deal
June 04, 2015 at 11:53 AM EDT
Bluebird bio Inc (NASDAQ: BLUE) and Celgene Corporation (NASDAQ: CELG) announced a restructuring of its CAR-T collaboration this ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.